The Johns Hopkins CCNE is one of several NCI-funded centers launched through a program that started in 2005. The CCNE program was established to create multi-institutional hubs that integrate nanotechnology across the cancer research continuum to provide new solutions for the diagnosis and treatment of cancer.
- NCI Alliance for Nanotechnology in Cancer – http://nano.cancer.gov/
- Other CCNE’s – http://nano.cancer.gov/action/programs/ccne.asp
From the press release
Faculty members associated with The Johns Hopkins Institute for NanoBioTechnology (INBT) have received a $13.6 million grant from the National Cancer Institute (NCI), to establish a Center of Cancer Nanotechnology Excellence (CCNE). The Center will be directed by Peter Searson, Joseph R. and Lynn C. Reynolds Professor of Materials Science and Engineering in the Whiting School of Engineering and also the director of INBT. Martin Pomper, professor of radiology and oncology at the Johns Hopkins School of Medicine and also the Sidney Kimmel Comprehensive Cancer Center, will serve as co-director.